117 related articles for article (PubMed ID: 22993361)
1. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement.
Zaki MA; Robbins JR; Fatteh S; Mahan MG; Hanna RK; Elshaikh MA
Anticancer Res; 2012 Sep; 32(9):4061-5. PubMed ID: 22993361
[TBL] [Abstract][Full Text] [Related]
2. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA
Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871
[TBL] [Abstract][Full Text] [Related]
3. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
4. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
5. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
6. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence.
Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082
[TBL] [Abstract][Full Text] [Related]
7. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.
Elshaikh MA; Al-Wahab Z; Mahdi H; Albuquerque K; Mahan M; Kehoe SM; Ali-Fehmi R; Rose PG; Munkarah AR
Gynecol Oncol; 2015 Feb; 136(2):235-9. PubMed ID: 25511158
[TBL] [Abstract][Full Text] [Related]
8. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
9. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
10. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
[TBL] [Abstract][Full Text] [Related]
13. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
[TBL] [Abstract][Full Text] [Related]
14. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
[TBL] [Abstract][Full Text] [Related]
16. Is time to recurrence after hysterectomy predictive of survival in patients with early stage endometrial carcinoma?
Robbins JR; Yechieli R; Laser B; Mahan M; Rasool N; Elshaikh MA
Gynecol Oncol; 2012 Oct; 127(1):38-42. PubMed ID: 22796549
[TBL] [Abstract][Full Text] [Related]
17. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.
Sagae S; Saito T; Satoh M; Ikeda T; Kimura S; Mori M; Sato N; Kudo R
Oncology; 2004; 67(5-6):344-50. PubMed ID: 15713989
[TBL] [Abstract][Full Text] [Related]
18. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
Isrow D; Burmeister C; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: a single institution study.
Gayar OH; Patel S; Schultz D; Mahan M; Rasool N; Elshaikh MA
Int J Gynecol Cancer; 2014 Jan; 24(1):97-101. PubMed ID: 24264358
[TBL] [Abstract][Full Text] [Related]
20. The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
Chan JK; Wu H; Cheung MK; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2007 Aug; 106(2):282-8. PubMed ID: 17662377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]